Cell News and Research

RSS

Olympus to showcase next generation of inverted microscope systems at EMBO Meeting 2013

Demonstrating the very latest in live cell imaging technologies, Olympus will exhibit its range of IX3 inverted microscope frames with associated software and accessories at the upcoming European Molecular Biology Organisation Meeting 2013, taking place in Amsterdam on 21-24 September.

From Evident Corporation - Life Sciences 5 Sep 2013

ESMO recognises oncologists with prestigious awards

The European Society for Medical Oncology, the leading pan-European organisation representing medical oncology professionals, announced today the recipients of the annual society's prestigious awards, recognising excellence in oncology.

5 Sep 2013

Biologists discover quality check system for neurons

Biologists at the University of California, San Diego have identified a new component of the cellular mechanism by which humans and animals automatically check the quality of their nerve cells to assure they're working properly during development.

5 Sep 2013

Heart researchers to establish stronger cardiovascular network in Chicago area

Heart research in Chicago will enter a new era Sept. 20 when top researchers from all of Chicago's major academic medical centers meet at the American Heart Association's 2013 Chicago Research Network Symposium.

5 Sep 2013

TSRI scientists discover isoform of angiomotin protein responsible for tumorigenesis

A team led by scientists from The Scripps Research Institute (TSRI) have shown that a protein once thought to inhibit the growth of tumors is instead required for initial tumor growth. The findings could point to a new approach to cancer treatment.

5 Sep 2013

Brown University establishes research center to study attention and other related behaviors

With a major new federal grant, Brown University has established a research center to study key questions in the neuroscience of attention and related behaviors. The COBRE Center for Central Nervous System Function will encompass five projects, each led by a junior faculty member with mentoring from a more senior professor, with the dual goals of better explaining the brain and generating potential new ideas for addressing disorders such as autism.

5 Sep 2013

Tel Aviv University researchers use zoological methods to study people with serious mental disorders

Because animals can't talk, researchers need to study their behavior patterns to make sense of their activities. Now researchers at Tel Aviv University are using these zoological methods to study people with serious mental disorders.

5 Sep 2013

Case Western researchers establish Kruppel-like factors as master regulators of vascular health

Case Western Reserve researchers have identified a genetic factor that blocks the blood vessel inflammation that can lead to heart attacks, strokes and other potentially life-threatening events.

5 Sep 2013

Study shows benefit of chemotherapy on survival of elderly patients with SCLC

Although numerous randomized clinical trials have demonstrated a benefit of chemotherapy for patients with small-cell lung cancer (SCLC), these trials have predominantly compared different chemotherapy regimens rather than comparing chemotherapy to best supportive care. Some of them included chest radiation or prophylactic cranial irradiation. Moreover, many trials excluded elderly patients.

5 Sep 2013

£13M partnership to accelerate cancer-focused drug discovery launched by Queen's and Almac Discovery

A new -13 million partnership to accelerate cancer-focused drug discovery in Northern Ireland has been launched by Enterprise Minister Arlene Foster MLA.

5 Sep 2013

High-income and better hygiene countries exhibit much higher rates of Alzheimer's

New research has found a "very significant" relationship between a nation's wealth and hygiene and the Alzheimer's "burden" on its population. High-income, highly industrialised countries with large urban areas and better hygiene exhibit much higher rates of Alzheimer's.

5 Sep 2013

Parkin protein plays key role in destruction of bacteria that cause tuberculosis

A protein at the center of Parkinson's disease research now also has been found to play a key role in causing the destruction of bacteria that cause tuberculosis, according to scientists led by UC San Francisco microbiologist and tuberculosis expert Jeffery Cox, PhD.

5 Sep 2013

Research findings raise hope for new heart therapies

Many people who survive a heart attack find themselves back in the hospital with a failing heart just years later. And the outcome often is unfavorable, owing to limited treatment options. But scientists at Temple University School of Medicine's Cardiovascular Research Center recently found hope in an unlikely source - stem cells in cortical, or compact, bone.

5 Sep 2013

Latest study recommends accelerated radiotherapy for un-resected NSCLC patients

Radiotherapy with or without chemotherapy is increasingly being used in the curative treatment for un-resected non-small cell lung cancer (NSCLC). But, until now, researchers had not looked at the cost-effectiveness of the treatment.

5 Sep 2013

FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food and Drug Administration has granted Priority Review status for the Biologics License Application for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis.

5 Sep 2013

Southampton researchers investigates influence of mechanical forces on cellular, molecular processes

University of Southampton researchers are at the forefront of research into mechanobiology, an emerging field of science combining biology and engineering, which investigates the influence of mechanical forces on cellular and molecular processes.

5 Sep 2013

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Neurodyn Inc. announced today that it has acquired from Galantos Pharma GmbH, Mainz, Germany all assets related to their Alzheimer's prescription drug candidate - Memogain. Memogain has completed an extensive preclinical development program and is ready to proceed into Phase 1 clinical trials in late 2013. The terms of the acquisition were not disclosed.

5 Sep 2013

Cell News and Research

Olympus to showcase next generation of inverted microscope systems at EMBO Meeting 2013

ESMO recognises oncologists with prestigious awards

Biologists discover quality check system for neurons

Heart researchers to establish stronger cardiovascular network in Chicago area

TSRI scientists discover isoform of angiomotin protein responsible for tumorigenesis

Brown University establishes research center to study attention and other related behaviors

Tel Aviv University researchers use zoological methods to study people with serious mental disorders

Case Western researchers establish Kruppel-like factors as master regulators of vascular health

Study shows benefit of chemotherapy on survival of elderly patients with SCLC

£13M partnership to accelerate cancer-focused drug discovery launched by Queen's and Almac Discovery

High-income and better hygiene countries exhibit much higher rates of Alzheimer's

Parkin protein plays key role in destruction of bacteria that cause tuberculosis

Research findings raise hope for new heart therapies

Latest study recommends accelerated radiotherapy for un-resected NSCLC patients

FDA grants Priority Review status to Takeda's investigational drug vedolizumab for ulcerative colitis

Southampton researchers investigates influence of mechanical forces on cellular, molecular processes

Neurodyn acquires all assets related to new drug candidate Memogain from Galantos Pharma

Sirt1 Protein, Not Calorie Restriction, Extends Life Span

Boosting Your Brain Power With Sleep

Taconic To Promote And Sell Medicyte Hepatocyte Products

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News